A COMPARISON OF THE NEW PRESERVATION SOLUTION CELSIOR TO EURO-COLLINS AND UNIVERSITY OF WISCONSIN SOLUTIONS IN LUNG REPERFUSION INJURY1
- 1 January 1999
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 67 (1) , 152-155
- https://doi.org/10.1097/00007890-199901150-00025
Abstract
The lung is particularly susceptible to reperfusion injury, both experimentally and clinically after transplantation. The extracellular-type preservation solution Celsior, which has been predominantly studied in cardiac preservation, has components designed to prevent cell swelling, free radical injury, energy depletion, and calcium overload. Using an isolated blood-perfused rat lung model, we investigated whether Celsior would decrease preservation injury and improve lung function after cold ischemic storage and reperfusion compared to Euro-Collins (EC) and University of Wisconsin (UW) solutions. Lewis rat lungs were isolated, flushed with the respective cold preservation solution, and then stored at 4°C for 6 or 12 hr. After ischemic storage, the lung block was suspended from a force transducer, ventilated with 100% O2, and reperfused for 90 min with fresh blood via a cannula in the pulmonary artery. Lung compliance, alveolar-arterial oxygen difference, and outflow oxygen tension were all measured. The capillary filtration coefficient (K f), a sensitive measure of changes in microvascular permeability, was determined. For 6 hr of cold storage, lungs stored in Celsior had lower K f values than those stored in EC, indicating decreased microvascular permeability. No other significant differences were noted between Celsior and EC or UW. For 12 hr of cold storage, Celsior provided increased oxygenation, decreased alveolar-arterial O2 differences, increased compliance, and decreased K f values as compared to both EC and UW. Celsior provides better lung preservation than EC or UW as demonstrated by increased oxygenation, decreased capillary permeability, and improved lung compliance, particularly at 12-hr storage times. These results are highly relevant, inasmuch as EC and UW are the most common clinically used lung preservation solutions. Further studies of Celsior in experimental and clinical lung transplantation, as well as in other solid organs, are indicated.Keywords
This publication has 13 references indexed in Scilit:
- Addition Of A Mast Cell Stabilizing Compound To Organ Preservation Solutions Decreases Lung Reperfusion InjuryThe Journal of Thoracic and Cardiovascular Surgery, 1998
- PROTECTIVE EFFECT OF REDUCED GLUTATHIONE ON ENDOTHELIAL FUNCTION OF CORONARY ARTERIES SUBJECTED TO PROLONGED COLD STORAGETransplantation, 1997
- Both blood and crystalloid-based extracellular solutions are superior to intracellular solutions for lung preservationThe Journal of Thoracic and Cardiovascular Surgery, 1996
- Obliterative bronchiolitis after lung and heart-lung transplantationThe Annals of Thoracic Surgery, 1995
- Impact of initial flush potassium concentration on the adequacy of lung preservationThe Journal of Thoracic and Cardiovascular Surgery, 1995
- Experimental evaluation Celsior, a new heart preservation solutionEuropean Journal of Cardio-Thoracic Surgery, 1994
- Early cellular events in the lung allograftThe Annals of Thoracic Surgery, 1992
- EXAMINATION OF THE ROLE OF THE IMPERMEANTS LACTOBIONATE AND RAFFINOSE IN A MODIFIED UW SOLUTIONTransplantation, 1990
- THE SUPERIORITY OF AN EXTRACELLULAR FLUID SOLUTION OVER EURO-COLLINS' SOLUTION FOR PULMONARY PRESERVATIONTransplantation, 1990
- PRINCIPLES OF SOLID-ORGAN PRESERVATION BY COLD STORAGETransplantation, 1988